Shehnaaz Suliman
SVP, Corp Dev & Strategy, Theravance Biopharma, Inc.
Companies
- 10X GenomicsBoard member Sep 11, 2019 to now1
- Ultragenyx Pharmaceutical Inc.Board member Feb 1, 2019 to now2
- Alector (United States)Chief operating officer Dec 12, 2019 to Dec 14, 20213
- Alector (United States)President Dec 12, 2019 to Dec 14, 20213
- Theravance Biopharma, Inc.SVP, Corp Dev & Strategy Aug 3, 2017 to Feb 22, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
10X Genomics TXG23,792 shares5$1.7M at $69.95Sep 22, 2026- Ultragenyx Pharmaceutical Inc. RARE27,951 shares6$418.1K at $14.96May 18, 2026
- Alector (United States) ALEC102,598 shares7$198.5K at $1.94Dec 13, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 22, 2026Sold 1,222 shares at $82.28 of 10X Genomics5
- Sep 22, 2026Sold 2,270 shares at $81.67 of 10X Genomics5
- Sep 22, 2026Sold 1,325 shares at $80.82 of 10X Genomics5
- Sep 22, 2026Sold 614 shares at $79.51 of 10X Genomics5
- Sep 22, 2026Sold 292 shares at $78.20 of 10X Genomics5
- Aug 24, 2026Sold 1,646 shares at $63.97 of 10X Genomics8
- Aug 24, 2026Sold 561 shares at $62.73 of 10X Genomics8
- Jun 16, 2026Sold 364 shares at $33.27 of 10X Genomics9
- Jun 16, 2026Sold 5,359 shares at $32.59 of 10X Genomics9
- Jun 4, 2026Granted 8,829 shares of 10X Genomics10
- May 18, 2026Sold 5,740 shares at $25.12 of Ultragenyx Pharmaceutical Inc.6
- May 14, 2026Granted 7,751 shares of Ultragenyx Pharmaceutical Inc.6
- Jun 3, 2025Granted 15,357 shares of 10X Genomics11
- May 15, 2025Granted 5,740 shares of Ultragenyx Pharmaceutical Inc.12
- Jun 18, 2024Granted 5,345 shares of Ultragenyx Pharmaceutical Inc.13
- Jun 11, 2024Granted 8,649 shares of 10X Genomics14
- Jun 14, 2023Granted 1,865 shares of 10X Genomics15
- Jun 7, 2023Granted 3,860 shares of Ultragenyx Pharmaceutical Inc.16
- Jun 24, 2022Granted 3,300 shares of Ultragenyx Pharmaceutical Inc.17
- Jun 15, 2022Granted 2,120 shares of 10X Genomics18
- Dec 13, 2021Sold 10,898 shares at $21.73 of Alector (United States)7
- Dec 13, 2021Sold 64,102 shares at $21.16 of Alector (United States)7
- Dec 13, 2021Exercised options 75,000 shares at $17.23 of Alector (United States)7
- Dec 10, 2021Sold 8,874 shares at $22.33 of Alector (United States)7
- Dec 10, 2021Sold 66,126 shares at $21.69 of Alector (United States)7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAR10X Genomics, Board member
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Aug 26, 2026
- 9SEC EDGARForm 4 filed Jun 18, 2026
- 10SEC EDGARForm 4 filed Jun 8, 2026
- 11SEC EDGARForm 4 filed Jun 5, 2025
- 12SEC EDGARForm 4 filed May 19, 2025
- 13SEC EDGARForm 4 filed Jun 20, 2024
- 14SEC EDGARForm 4 filed Jun 13, 2024
- 15SEC EDGARForm 4 filed Jun 16, 2023
- 16SEC EDGARForm 4 filed Jun 9, 2023
- 17SEC EDGARForm 4 filed Jun 28, 2022
- 18SEC EDGARForm 4 filed Jun 17, 2022